Bibliographical study of the concurrent existence of anticentromere and antitopoisomerase I antibodies

Clinical Rheumatology

Volumn 19, Issue 6, 2000, Pages 435-441

  Kikuchi, M ^a,b   Inagaki, T ^a  

^a Nagoya shi Kouseiin Geriatric Hosp   (Japan)

^b NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Anticentromere antibody; Antitopoisomerase I antibody

Indexed keywords

ANTIBODY; DNA TOPOISOMERASE;

ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY TITER; CARDIOVASCULAR SYSTEM; CENTROMERE; ESOPHAGUS FUNCTION; HUMAN; PRIORITY JOURNAL; REVIEW; SCLERODERMA; SKIN DEFECT; SYSTEMIC SCLEROSIS;

ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; CENTROMERE; CHILD; CONNECTIVE TISSUE DISEASES; DNA TOPOISOMERASES, TYPE I; FEMALE; HUMANS; MALE; MIDDLE AGED; SCLERODERMA, SYSTEMIC;

EID: 0034501638     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100670070001     Document Type: Review

References (57)

1. Autoantibodies in the diagnosis of systemic rheumatic diseases
2. Evaluation, signs and symptoms. Laboratory tests in rheumatic disorders
3. Association of anti-centromere and anti-Scl 70 antibodies in scleroderma. Report of two cases
4. Autoantibodies to topoisomerase I in primary biliary cirrhosis
5. Clinical associations of anticentromere antibodies and antibodies to topoisomerase I. A study of 355 patients
6. Racial differences in antinuclear antibody patterns and clinical manifestations of scleroderma
7. Are ACA and Scl 70 antibodies mutually exclusive?
8. Antikinetochore and antitopoisomerase I antibodies in systemic scleroderma: Comparative study using immunoblotted recombinant antigens, immunofluorescence, and double immunodiffusion
9. The analysis of antinuclear and antinucleolar autoantibodies of scleroderma by radioimmunoprecipitation assays
10. Cutaneous and serologic subsets of systemic sclerosis
11. A case of rheumatoid arthritis associated with progressive systemic sclerosis and primary biliary cirrhosis in the presence of various autoantibodies
12. A patient with systemic sclerosis, severe cytopenias and the simultaneous presence of anti-centromere and anti-Scl-70-antibodies
13. Test performance in systemic sclerosis: Anti-centromere and anti-Scl-70 antibodies
14. Preliminary criteria for the classification of systemic sclerosis (scleroderma)
15. The CREST syndrome: A distinct serologic entity with anticentromere antibodies
16. Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome
17. Serological markers in progressive systemic sclerosis: Clinical correlations
18. Frequency and clinical significance of anticentromere and anti Scl-70 antibodies in an English connective tissue disease population
19. Antinuclear antibodies in the relatives of patients with systemic sclerosis
20. Antinuclear antibodies in progressive systemic sclerosis
21. Scl 70 antibody - A specific marker of systemic sclerosis
22. A highly conserved 72,000 dalton centromeric antigen reactive with autoantibodies from patients with progressive systemic sclerosis
23. Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis
24. Antinuclear antibodies in scleroderma, mixed connective tissue disease and 'primary' Raynaud's phenomenon
25. Anti-Scl-70 antibodies detected by immunoblotting in progressive systemic sclerosis: Specificity and clinical correlations
26. Marker antibodies in scleroderma and polymyositis: Clinical associations
27. Clinical significance of antinuclear antibodies in Japanese patients with systemic sclerosis
28. Serological profiles as prognostic clues for progressive systemic scleroderma: The Italian experience
29. Antinuclear antibodies in systemic sclerosis
30. Antinuclear antibody profile in Italian patients with connective tissue diseases
31. Antinuclear antibodies in patients with scleroderma (systemic sclerosis) and in their blood relatives and spouses
32. Anticardiolipin, anticentromere and anti-Scl-70 antibodies in patients with systemic sclerosis and severe digital ischaemia
33. Immunologic parameters in systemic sclerosis
34. A study of scleroderma in South Australia: Prevalence, subset characteristics and nailfold capillaroscopy
35. Molecular analysis of HLA-DPB1 alleles in idiopathic systemic sclerosis patients and uranium miners with systemic sclerosis
36. Epidemiological analysis of prognosis of 496 Japanese patients with progressive systemic sclerosis (SSc)
37. A longitudinal study of pulmonary function in Danish patients with systemic sclerosis
38. Clinical significance of subcutaneous calcinosis in patients with systemic sclerosis. Does diltiazem induce its regression?
39. Anti-RNA polymerase and other autoantibody specificities in systemic sclerosis
40. Epidemiology of systemic sclerosis [scleroderma]
41. Progressive systemic sclerosis (scleroderma)
42. Classification of systemic sclerosis (scleroderma): Relationship of cutaneous subgroups in early disease to outcome and serological reactivity
43. The 1982 revised criteria for the classification of systemic lupus erythematosus
44. 1958 Revision of diagnostic criteria for rheumatoid arthritis
45. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
46. A computer-assisted analysis of 153 patients with polymyositis and dermatomyositis
47. Specificity of anti-Scl-70 antibodies in scleroderma: Increased sensitivity of detection using purified DNA topoisomerase I from calf thymus
48. Progressive systemic sclerosis in the elderly
49. Systemic sclerosis in the elderly
50. Prevalence of selected autoantibodies in different elderly subpopulations
51. Prevalence and disease associations of certain autoantibodies in elderly patients
52. High prevalence of anti-cardiolipin and other autoantibodies in healthy elderly population
53. Prevalence of organ-specific and non organ-specific autoantibodies in healthy centenarians
54. Proteins of the inner and outer centromere of mitotic chromosomes
55. Microinjection of antibodies to centromere protein CENP-A arrests cells in interphase but does not prevent mitosis
56. Cytogenetic survey in systemic sclerosis: Correlation of aneuploidy with the presence of anticentromere antibodies
57. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis